Thyroid Cancer Drugs Market Infrastructure Growth and Development 2018 to 2026 Global Key Players Biovista, Vascular Biogenics, Azaya Therapeutics, Bionomics, Bayer, Eisai, Bio-Path Holdings, GlaxoSmithKline plc, AstraZeneca plc.

In the recent past, an increasing number of thyroid cancers were diagnosed at an early stage of the treatment as several new technologies have arrived with drugs. Advanced treatments resulting in long-term survival, minimum complications of surgery and improved quality of life in a cost-effective way. The main types of thyroid cancer include differentiated, medullary, and anaplastic thyroid cancer. Among these, anaplastic thyroid cancer is characterized by an aggressive undifferentiated tumor. Apart from these, the other types of thyroid cancer include thyroid lymphomas, thyroid sarcomas, parathyroid cancer or other rare thyroid tumors.

Download PDF Brochure of Market Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1710

Thyroid Cancer Drugs Market Drivers:

Increasing prevalence of thyroid cancer is expected to drive the growth of the thyroid cancer drugs market. For instance, according to National Cancer Institute (NCI), 2013-2015 data findings, around1.2% of men and women are expected to be diagnosed with thyroid cancer at some point during their lifetime, in the U.S. Moreover, according to the NCI 2018 data findings, in 2018, there were an estimated 53,990 new cases of thyroid cancer and an estimated 2,060 people are expected to die due to thyroid cancer, in the U.S. Moreover, according to Cancer Research UK, 2015 data findings, in the U.K. there were 3,528 new cases of thyroid cancer registered in 2015. According to the same source, thyroid cancer accounted to register 1% of all cancer cases in 2015, which includes 27% of thyroid cancer cases in males, and 73% in females, in the U.K. Furthermore, according to Cancer Research UK, the lifetime risk of developing thyroid cancer is around 1 in 480 for men and around 1 in 180 for women, in 2012 in the U.K.

Thyroid Cancer Drugs Market - Regional Analysis

Geographically, thyroid cancer drugs market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds the dominant position in thyroid cancer drugs market. This is owing to the growing prevalence of thyroid cancer in this region. According to the National Cancer Institute (NCI) 2018 data findings, in 2015, there were an estimated 765,547 people living with thyroid cancer in the U.S. Moreover, according to the same source, an estimated 53,990 new cases of thyroid cancer are expected to be registered in 2018, representing 3.1% of all new cancer cases, in 2018.

Thyroid Cancer Drugs Market Competitive Landscape:

Some of the key players operating in thyroid cancer drugs market include Biovista, Vascular Biogenics, Azaya Therapeutics, Bionomics, Bayer, Eisai, Bio-Path Holdings, Takeda Pharmaceutical Company, GlaxoSmithKline plc, and AstraZeneca Plc. Key players in the market are focusing on organic growth strategies, in order to enhance its market share and retain its position in the market. For instance, in May 2016, U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for AstraZeneca’s investigational MEK 1/2 inhibitor, selumetinib for adjuvant treatment of patients with stage III or IV differentiated thyroid cancer (DTC). Moreover, in April 2011, FDA approved AstraZeneca’s kinase inhibitor vandetanib for the treatment of unresectable or metastatic medullary thyroid cancer.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1710

Thyroid Cancer Drugs Market Taxonomy:

• By Drug Type:

- Ipilimumab
- Cabozantinib-S-Malate
- Caprelsa (Vandetanib)
- Doxorubicin Hydrochloride
- Cometriq (Cabozantinib-S-Malate)
- Lenvatinib Mesylate
- Nivolumab
- Vandetanib
- Others

• By End Users:

- Hospitals
- Oncology Clinics
- Research Organizations
- Others

• By Geography:

- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.